Site Search
New gene panel enhances brain tumor profiles - Insights
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Pediatric Autoimmune CNS Disorders Evaluation - Insights
The clinical presentations, evaluation (including diagnostic antibody testing), and treatment of autoimmune pediatric CNS disorders, including encephalitides and myelopathies.
Hereditary Oncology Testing [Test in Focus] - Insights
Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant...
Find out how our unique tests, methodologies, and reference ranges provide fast, accurate results for complex pediatric gastroenterology conditions.
Learn how we partner with Mayo Clinic’s biochemical genetics laboratory for the most sophisticated technology in pediatric neurogenetic testing.
Chromosomal microarray better informs brain tumor diagnosis - Insights
Molecular biomarkers are a critical component in the treatment of adult and pediatric brain tumors. Robert Jenkins, M.D., Ph.D., explains how Mayo Clinic Laboratories' chromosomal microarray provides more comprehensive and accurate tumor...
Hereditary oncology: Molecular testing for solid tumors - Insights
In this episode of Lab Medicine Rounds, Sounak Gupta, M.B.B.S., Ph.D., assistant professor of Laboratory Medicine and Pathology at Mayo Clinic, discusses hereditary oncology and the importance of performing molecular testing of solid...
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Disaccharidase Activity Panel [Test in Focus] - Insights
Pua Hopson, D.O., discusses Mayo Clinic Labs’ new disaccharidase activity panel, which measures levels of five digestive enzymes to identify deficiencies that cause carbohydrate maldigestion and can lead to chronic conditions like celiac...
Learn more about our pediatric oncology testing, which was carefully developed by a team of experts to provide efficient, actionable answers.
Find out more about how Mayo Clinic Laboratories’ pediatric testing covers the full range of clinical specialties.
Novel malabsorption panel speeds diagnosis - Insights
Puanani Hopson, D.O., explains how Mayo Clinic Laboratories’ malabsorption panel can provide timelier diagnosis for children with chronic diarrhea or unexplained weight loss. The novel panel, which bundles four existing tests, requires just...
Plasma Test Increases Access to Alzheimer's Testing: Alicia Algeciras-Schimnich, Ph.D. - Insights
Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D. Answers From the Lab In this episode of “Answers From the Lab,”
Neurology study validates Alzheimer's assays - Insights
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates specimen collections and access to archived samples to support clinical trials and diagnostic validation projects that advance healthcare. In this collaboration example, learn...
Reflex Test Guides Precise Care for Arsenic Exposure: Paul Jannetto, Ph.D. - Insights
Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the...
Our renal diagnostics are backed by a multidisciplinary approach and an award-winning team of Mayo Clinic nephrology experts, pathologists, and laboratory scientists who work at the intersection of research and patient care.
Applying MASSFIX to Urine Samples - Insights
In this month's "Hot Topic," David Murray, M.D., Ph.D., reviews the role of urine testing for monoclonal gammopathies and discusses Mayo Clinic’s use of MASSFIX to replace traditional immunofixation testing.
Results report simplifies urine test interpretation: John Lieske, M.D. - Insights
John Lieske, M.D., explains why it's now easier for clinicians to pull information from Mayo Clinic Laboratories' supersaturation test report. An updated format summarizes complex information to help guide the treatment of kidney stones.
State-of-the-art genetics panel optimizes kidney disease treatment - Insights
Linnea M. Baudhuin, Ph.D., and Emily K. Thoreson, M.S., CGC, explain how Mayo Clinic Laboratories renal genetics testing provides comprehensive, accurate and actionable results. Identifying a genetic cause helps guide the complex decisions...
Anti-hypertensive drug monitoring - Insights
Learn how Mayo Clinic Laboratories’ anti-hypertensive drug panel can assist physicians in understanding the reasons for resistant hypertension in patients.
Learn how our renal testing delivers accurate answers in concise reports that improve outlooks for patients with glomerular diseases.
Assay identifies most known membranous nephropathy antigens: Sanjeev Sethi, M.D., Ph.D. - Insights
Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal...
Learn how our renal genetic testing was developed by a team of experts and is among the most comprehensive diagnostic testing available.
Patients with elevated LDL or "bad" cholesterol face even greater risk if their levels of small dense LDL cholesterol are also high. Vlad Vasile, M.D., Ph.D., and Leslie Donato, Ph.D., explain how Mayo Clinic Laboratories' sdLDL-c assay...
Urinary stone services - Insights
Learn how our approach to kidney stone services and concise reporting enable accurate interpretation to guide clinical decisions.
New AI-augmented test refines kidney stone analysis - Insights
Since March 2019, Paul Jannetto, Ph.D., director of the Metals Laboratory at Mayo Clinic, along with his colleagues across the enterprise and his laboratory staff, have developed, validated, and implemented an artificial intelligence...
Renal Pathology at Mayo Clinic Laboratories
Mayo Clinic Laboratories’ is integrated with the Renal Biopsy Laboratory in the Department of Laboratory Medicine and Pathology at Mayo Clinic. Board-certified pathologist have a special interest in non-neoplastic disease of the kidney and...
NELL-1 [Test in Focus] - Insights
Sanjeev Sethi, M.D., Ph.D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic certainty and...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
4 statistics that showcase the broad impact of laboratory medicine - Insights
Medical Laboratory Professionals Week is a time to appreciate the profound impact of laboratory medicine on healthcare and innovation.
Featured new tests in quarter one of 2025 - Insights
In the first quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.
Dr. William Morice provides insights on the evolving technologies in medicine - Insights
In a Fierce Healthcare article, Dr. William Morice highlights AI, digital pathology, and mass spectrometry as key advancements revolutionizing healthcare diagnostics and treatment.
Global Vigilance in Preventing Infectious Disease Outbreaks: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the...
Respiratory disease - Insights
Learn about our suite of tests that are designed to detect a variety of respiratory viruses, including COVID-19, influenza, and RSV.
Why Mpox is a Public Health Emergency: Matthew Binnicker, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Matthew Binnicker, Ph.D., professor of laboratory medicine and pathology and clinical virologist...
What's Causing Outbreaks of Preventable Infectious Diseases: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent...
Helicobacter pylori - Insights
Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.
Learn more about our comprehensive menu of COVID-19 molecular, serology, and related testing.
Metagenomic Sequencing - A Tool for Diagnosis of Central Nervous System Infection - Insights
PACE/State of FL - Metagenomic sequencing for diagnosing central nervous system infection. Content will be shared regarding technical details, clinical applications, and results interpretation, drawing on both current literature and...
GI parasitic disease - Insights
Learn about our focused approach to gastrointestinal disease testing and the identification of the type of parasite present in a sample.
Vector-borne diseases - Insights
Browse our full menu of individual tests and panels that aid in the diagnosis of vector-borne diseases.
The Impacts of STI Testing Innovation: Elitza Theel, Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for...
Infectious diseases - Insights
Mayo Clinic BioPharma Diagnostics offers access to the clinical trial infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our...
Significant Infectious Disease Activity Continues: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss...
Preparing for Respiratory Viruses: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss...
Specialized testing diagnoses uncommon allergy to red meat: Joseph Ducaji - Insights
CT scans and hiatal/abdominal ultrasounds could not uncover why, whenever he ate steak, Joseph Ducaji experienced severe stomach problems, itchy hives, chills, and nausea. It took specialized testing from Mayo Clinic to unlock a...
Laboratory Medicine Central to Tick-Borne Disease Response: Bill Morice, M.D., Ph.D. - Insights
In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss...
Infectious Disease Pathology at Mayo Clinic Laboratories
We have the knowledge and experience in diagnosing infectious entities and discussing the different options for testing in the clinical microbiology laboratory.
Learn more about how Mayo Clinic Laboratories helps hospital laboratories reduce costs and grow revenue.
Learn more about how Mayo Clinic Laboratories’ test offerings and services can help hospital laboratories enhance patient care and laboratory performance.